Local staging of rectal cancer on MRI

MRI

First and second year — the floor first, then every step

Four numbers decide the treatment: distance from the anal verge, T stage, mesorectal fascia clearance, and extramural venous invasion.

Orient first

  • This report is a surgical and oncological planning document. The MESORECTAL FASCIA is the surgical plane, and the tumour's shortest distance to it is the single most consequential measurement — threatened at 1 mm or less.
  • EXTRAMURAL VENOUS INVASION is an independent adverse prognostic factor that is frequently under-reported. It is seen as tumour signal expanding a vein beyond the muscularis propria.
  • DEPTH of extramural spread in millimetres matters within T3 — T3a to T3d — and changes neoadjuvant decisions in a way "T3" alone does not.
  • HEIGHT from the anal verge and the relationship to the peritoneal reflection determine the operation, including whether the sphincter can be preserved.
  • For low tumours the ANAL SPHINCTER complex must be assessed separately: internal sphincter, intersphincteric plane, and external sphincter.

Acquire the study

  • High-resolution T2 WITHOUT fat suppression, in planes ORTHOGONAL TO THE TUMOUR — not to the patient. An oblique axial aligned to the rectal wall at the tumour is the defining sequence, and a body-axial plane over-stages by partial volume.
  • Sagittal T2 first to plan the oblique axial, and a coronal for low tumours to assess the sphincter.
  • Add DWI, which helps identify the tumour and assess response after neoadjuvant therapy.
  • No rectal distension for staging — it flattens the tumour and distorts the mesorectal fat.
  • Confirm which sequence you are on before judging any signal — see the MRI sequence primer.

The manoeuvre

  • Measure the distance from the ANAL VERGE to the lower edge of the tumour, and state whether it is low, mid or high.
  • State the relationship to the PERITONEAL REFLECTION.
  • Assign T stage, and for T3 give the DEPTH of extramural spread in millimetres.
  • Measure the shortest distance from tumour (or a deposit or node) to the MESORECTAL FASCIA and state which structure is closest.
  • Assess EXTRAMURAL VENOUS INVASION explicitly, and state present or absent rather than omitting it.
  • Assess mesorectal and extramesorectal nodes by morphology — irregular border and mixed signal matter more than size.
  • For low tumours, assess the intersphincteric plane and both sphincters.
  • Look for tumour deposits, which are counted separately from nodes.
  • After neoadjuvant therapy, use a tumour regression grading system and name it.

What confirms it

  • A threatened margin is tumour, a deposit or a node within 1 mm of the mesorectal fascia on a correctly-aligned oblique axial image.

What licenses you to exclude it

  • ⚠️ A body-axial study cannot exclude margin involvement — partial volume averaging across the rectal wall both over- and under-calls. Report the plane as inadequate and recommend a correctly-aligned study.
  • MRI cannot reliably distinguish a small T1 from a T2 tumour; endoanal ultrasound is the study for early disease, and saying so beats guessing.
  • After radiotherapy, fibrosis and residual tumour overlap on T2 — assess with DWI and say that only tissue settles it.

The classic misread

  • Staging on body-axial rather than tumour-orthogonal images.
  • Omitting extramural venous invasion.
  • Giving "T3" with no depth in millimetres.
  • Distending the rectum for a staging study.

Reference values

Each value carries the caveat that keeps it from being misused. Normal limits and diagnostic criteria are kept apart on purpose: a disease cut-off read as a normal range is the more dangerous mistake.

Diagnostic criteria

  • Mesorectal fascia · tumour or node distance to the mesorectal fasciathreatened at 1 mm or less

    Report the clearance in millimetres and name the closest structure — the figure drives neoadjuvant decisions.

    MRI

See it on real cases

Direct links to Radiopaedia — the reference article and worked cases with their images. Each opens on Radiopaedia.

Key papers

Reviews and guidelines from RSNA, ESR and related journals. Each opens at its DOI.

  1. MRI of Rectal Cancer: Tumor Staging, Imaging Techniques, and Management ↗Horvat N, Carlos Tavares Rocha C, Clemente Oliveira B, et al. · RadioGraphics 2019RSNA · PubMed
  2. MRI to guide clinical management of rectal cancer: updated consensus recommendations from the European Society of Gastrointestinal and Abdominal Radiology (ESGAR): PART II-Restaging and response evaluation ↗ESGAR Rectal Imaging Guideline Group · European Radiology 2026ESR · PubMed
  3. MRI to guide clinical management of rectal cancer: updated consensus recommendations from the European Society of Gastrointestinal and Abdominal Radiology (ESGAR)-PART I primary staging ↗ESGAR Rectal Imaging Guideline Group · European Radiology 2026ESR · PubMed
  4. MRI for Rectal Cancer: Updates and Controversies-AJR Expert Panel Narrative Review ↗Khasawneh H, Khatri G, Sheedy SP, et al. · AJR 2025ARRS · PubMed
  5. MRI of rectal cancer-relevant anatomy and staging key points ↗Santiago I, Figueiredo N, Parés O, et al. · Insights into Imaging 2020ESR · PubMed

More searches

More in Oncology, nuclear and IR